Cargando…
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253713/ https://www.ncbi.nlm.nih.gov/pubmed/33566240 http://dx.doi.org/10.1245/s10434-020-09481-8 |
_version_ | 1783717572157374464 |
---|---|
author | Colombo, Carla De Leo, Simone Di Stefano, Marta Trevisan, Matteo Moneta, Claudia Vicentini, Leonardo Fugazzola, Laura |
author_facet | Colombo, Carla De Leo, Simone Di Stefano, Marta Trevisan, Matteo Moneta, Claudia Vicentini, Leonardo Fugazzola, Laura |
author_sort | Colombo, Carla |
collection | PubMed |
description | BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and were followed up. RESULTS: Event-free survival by Kaplan–Meier curves was significantly higher after TT than after LT for the patients with either low-risk (P = 0.004) or intermediate-risk (P = 0.032) tumors. At the last follow-up visit, the prevalence of event-free patients was higher in the TT group than in the LT low-risk group (95% and 87.5%, respectively; P = 0.067) or intermediate-risk group (89% and 50%; P = 0.008). No differences in persistence prevalence were found among microcarcinomas treated by LT or TT (low risk, P = 0.938 vs. intermediate-risk, P = 0.553). Nevertheless, 15% of the low-risk and 50% of the intermediate-risk microcarcinomas treated by LT were submitted to additional treatments. On the other hand, macrocarcinomas were significantly more persistent if treated with LT than with TT (low-risk, P = 0.036 vs. intermediate-risk, P = 0.004). Permanent hypoparathyroidism was more frequent after TT (P = 0.01). After LT, thyroglobulin (Tg)/thyroid-stimulating hormone (TSH) had shown decreasing trend in 68% of the event-free patients and an increasing trend in the persistent cases. CONCLUSIONS: Lobectomy can be proposed for low-risk microcarcinomas, although in a minority of cases, additional treatments are needed, and a longer follow-up period usually is required to confirm an event-free outcome compared with that for patients treated with TT. On the other hand, to achieve an excellent response, TT should be favored for intermediate-risk micro- and macro-DTCs despite the higher frequency of postsurgical complications. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09481-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8253713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-82537132021-07-20 Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review Colombo, Carla De Leo, Simone Di Stefano, Marta Trevisan, Matteo Moneta, Claudia Vicentini, Leonardo Fugazzola, Laura Ann Surg Oncol Endocrine Tumors BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and were followed up. RESULTS: Event-free survival by Kaplan–Meier curves was significantly higher after TT than after LT for the patients with either low-risk (P = 0.004) or intermediate-risk (P = 0.032) tumors. At the last follow-up visit, the prevalence of event-free patients was higher in the TT group than in the LT low-risk group (95% and 87.5%, respectively; P = 0.067) or intermediate-risk group (89% and 50%; P = 0.008). No differences in persistence prevalence were found among microcarcinomas treated by LT or TT (low risk, P = 0.938 vs. intermediate-risk, P = 0.553). Nevertheless, 15% of the low-risk and 50% of the intermediate-risk microcarcinomas treated by LT were submitted to additional treatments. On the other hand, macrocarcinomas were significantly more persistent if treated with LT than with TT (low-risk, P = 0.036 vs. intermediate-risk, P = 0.004). Permanent hypoparathyroidism was more frequent after TT (P = 0.01). After LT, thyroglobulin (Tg)/thyroid-stimulating hormone (TSH) had shown decreasing trend in 68% of the event-free patients and an increasing trend in the persistent cases. CONCLUSIONS: Lobectomy can be proposed for low-risk microcarcinomas, although in a minority of cases, additional treatments are needed, and a longer follow-up period usually is required to confirm an event-free outcome compared with that for patients treated with TT. On the other hand, to achieve an excellent response, TT should be favored for intermediate-risk micro- and macro-DTCs despite the higher frequency of postsurgical complications. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09481-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2021-02-10 2021 /pmc/articles/PMC8253713/ /pubmed/33566240 http://dx.doi.org/10.1245/s10434-020-09481-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Endocrine Tumors Colombo, Carla De Leo, Simone Di Stefano, Marta Trevisan, Matteo Moneta, Claudia Vicentini, Leonardo Fugazzola, Laura Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title | Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title_full | Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title_fullStr | Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title_full_unstemmed | Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title_short | Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review |
title_sort | total thyroidectomy versus lobectomy for thyroid cancer: single-center data and literature review |
topic | Endocrine Tumors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253713/ https://www.ncbi.nlm.nih.gov/pubmed/33566240 http://dx.doi.org/10.1245/s10434-020-09481-8 |
work_keys_str_mv | AT colombocarla totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT deleosimone totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT distefanomarta totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT trevisanmatteo totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT monetaclaudia totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT vicentinileonardo totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview AT fugazzolalaura totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview |